Seizure Disorders
Products Related to Seizure Disorders(93)
- GC49472Methylmalonic Acid-d3CAS: 42522-59-8Purity: >99.00%
Methylmalonic Acid-d3(Methylpropanedioic acid-d3)는 Methylmalonic acid로 표시된 중수소입니다. 메틸말론산(Methylmalonate)은 암에서 비타민 B-12 결핍의 지표입니다.
- GC497524,5-Desisopropylidene TopiramateCAS: 106881-41-8Purity: >95.00%
An inactive metabolite of topiramate
- GC49756Safinamide AcidCAS: 1160513-60-9Purity: >95.00%
A potential impurity found in commercial preparations of safinamide
- GC49782L-Phenylalanine-13C6CAS: 180268-82-0Purity: >98.00%
L-페닐알라닌-13C6((S)-2-아미노-3-페닐프로피온산-13C6)은 13C로 표지된 L-페닐알라닌입니다.
- GC4982010,11-dihydro-10,11-dihydroxy CarbamazepineCAS: 35079-97-1Purity: >95.00%
A metabolite of carbamazepine and oxcarbazepine
- GC498611-Carboxycyclohexaneacetic AcidCAS: 67950-95-2Purity: >95.00%
A potential impurity in commercial preparations of gabapentin
- GC49865γ-D-Glutamylglycine (trifluoroacetate salt)CAS: 71822-19-0Purity: >95.00%
An excitatory amino acid antagonist
- GC52020Lamotrigine-d3CAS: 1132746-94-1Purity: >99.00%
An internal standard for the quantification of lamotrigine
- GC52484Purified Ganglioside Mixture (bovine) (ammonium salt)Purity: >98.00%
A mixture of purified bovine gangliosides
- GC91946HexylHIBO (hydrobromide)Purity: >98.00%
HexylHIBO (hydrobromide)는 제1 군 메타abotropic glutamate 수용체의 길항제 (mGluRs;Kbs = 140와 110 μ M를 mGluR1 α와 mGluR5a, 각각)이다.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC49319 | Mebicar | 10095-06-4 | >98.00% | |
Tetramethylglycerol(Tetramethylglycoluril)은 항불안 활성과 함께 GABA 수용체에 작용하는 작은 분자입니다. | ||||
| GC49472 | Methylmalonic Acid-d3 | 42522-59-8 | >99.00% | |
Methylmalonic Acid-d3(Methylpropanedioic acid-d3)는 Methylmalonic acid로 표시된 중수소입니다. 메틸말론산(Methylmalonate)은 암에서 비타민 B-12 결핍의 지표입니다. | ||||
| GC49501 | Nirvanol | 631-07-2 | >98.00% | |
An active metabolite of mephenytoin | ||||
| GC49538 | Lamotrigine N2-oxide | 136565-76-9 | >95.00% | |
A metabolite of lamotrigine | ||||
| GC49752 | 4,5-Desisopropylidene Topiramate | 106881-41-8 | >95.00% | |
An inactive metabolite of topiramate | ||||
| GC49756 | Safinamide Acid | 1160513-60-9 | >95.00% | |
A potential impurity found in commercial preparations of safinamide | ||||
| GC49767 | CYM 2503 | 1308833-36-4 | >95.00% | |
CYM 2503은 추정되는 GalR2 양성 알로스테릭 조절제입니다. | ||||
| GC49782 | L-Phenylalanine-13C6 | 180268-82-0 | >98.00% | |
L-페닐알라닌-13C6((S)-2-아미노-3-페닐프로피온산-13C6)은 13C로 표지된 L-페닐알라닌입니다. | ||||
| GC49820 | 10,11-dihydro-10,11-dihydroxy Carbamazepine | 35079-97-1 | >95.00% | |
A metabolite of carbamazepine and oxcarbazepine | ||||
| GC49861 | 1-Carboxycyclohexaneacetic Acid | 67950-95-2 | >95.00% | |
A potential impurity in commercial preparations of gabapentin | ||||
| GC49865 | γ-D-Glutamylglycine (trifluoroacetate salt) | 71822-19-0 | >95.00% | |
An excitatory amino acid antagonist | ||||
| GC52020 | Lamotrigine-d3 | 1132746-94-1 | >99.00% | |
An internal standard for the quantification of lamotrigine | ||||
| GC52033 | S-Methyl-D-penicillamine | 29913-84-6 | >95.00% | |
A metabolite of D-penicillamine | ||||
| GC52473 | NVP-AAM077 | 2514919-70-9 | >95.00% | |
An NMDA receptor antagonist | ||||
| GC52484 | Purified Ganglioside Mixture (bovine) (ammonium salt) | - | >98.00% | |
A mixture of purified bovine gangliosides | ||||
| GC52496 | Sulfatide (bovine) (sodium salt) | - | >95.00% | |
A mixture of isolated bovine sulfatides | ||||
| GC90480 | Safinamide Metabolite NW 1689 | 405-85-6 | >95.00% | |
상품화된 사피나마이드 제제에서 발견된 잠재적인 불순물 | ||||
| GC90597 | LY2365109 (hydrochloride) | 1779796-27-8 | >95.00% | |
GlyT1a 억제제 | ||||
| GC91153 | Sulfonadyn-47 | - | >98.00% | |
다이나믹인 억제제 | ||||
| GC91906 | (R)-AS-1 | 2506367-95-7 | >95.00% | |
(R)-AS-1 는 흥분성 아미노산 트랜스퍼 단백질 2 EAAT2의 양변조 조절제입니다.글루타민산 섭취 시험에서의 EC50=11nM. | ||||
| GC91946 | HexylHIBO (hydrobromide) | - | >98.00% | |
HexylHIBO (hydrobromide)는 제1 군 메타abotropic glutamate 수용체의 길항제 (mGluRs;Kbs = 140와 110 μ M를 mGluR1 α와 mGluR5a, 각각)이다. | ||||